Compare MYSZ & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | VERO |
|---|---|---|
| Founded | 1999 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 4.0M |
| IPO Year | N/A | N/A |
| Metric | MYSZ | VERO |
|---|---|---|
| Price | $0.85 | $1.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 276.4K | ★ 17.4M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,512,000.00 | ★ $58,876,000.00 |
| Revenue This Year | $18.06 | N/A |
| Revenue Next Year | $36.03 | $10.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.73 | $1.39 |
| 52 Week High | $3.04 | $14.50 |
| Indicator | MYSZ | VERO |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 47.77 |
| Support Level | $0.82 | $1.39 |
| Resistance Level | $0.88 | $12.93 |
| Average True Range (ATR) | 0.07 | 0.73 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 17.81 | 2.86 |
My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.